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A 35mm slide showing the Fletcher-Peto graph was a key element in the carousel used for teaching 
medical students life course epidemiology in respiratory medicine.  The slide tracked various 
downwards trajectories in lung function from a peak of 100% at approximately age 25 years of age.  
Life does not begin at 25, but it has taken several decades for birth cohorts to map lung function 
trajectories from early life to adulthood.  These cohorts have led to the “modern” Fletcher-Peto 
curve which has a number of upwards trajectories from 0-25 years of age (Figure) some of which 
attain a “normal” 100% but some fall short of this peak through more than one trajectory.  The 
height of the peak in lung function achieved is a measure of respiratory “reserve” against fixed 
airways disease in later life. We are going to have to wait another 25 years for the birth cohorts to 
show whether those who fail to attain “normal” lung function are at increased risk for chronic 
obstructive pulmonary disease (COPD), but in the meantime we can reasonably assume that this 
hypothesis will be proven thanks to a cohort where reduced lung function in the first decade of life 
has been associated with increased risk of COPD in the sixth decade(1).  
What is still not clear is when the gradient of the upwards trajectory in lung function is determined 
and what might be done to alter it.  A paper in this edition has shed light on the very early origins of 
lung function (2).   What was previously understood was that, at a population level, low lung 
function in the first two months was weakly predictive of lung function in early adulthood (3, 4), and 
that low lung function in some infants may apparently resolve but persists in those with a family 
history of asthma or early onset atopy (5).  Work from other cohorts indicate that the development 
of asthma may lead to “deterioration” in lung function between early infancy and seven years of age 
(6) whilst improved air quality may lead to improved growth of lung function between ages 11 and 
15 years (7).  An additional factor associated with changing trajectory of lung function in early life is 
post-natal weight gain (8).   Accelerated postnatal growth may occur de novo or may represent 
“catch up” growth after suppressed antenatal growth, and any intervention aimed at influencing 
lung function outcome needs to understand whether to target the antenatal or post-natal period.  
The novelty of the study by den Dekker et al (2) is that it demonstrates two pathways to airway 
obstruction at ten years of age (i.e. reduced FEV1/FVC ratio).  Restricted antenatal growth (defined 
as a 0.67 reduction in z score) which is followed by normal or accelerated (“catch up”) postnatal 
growth is associated with reduced FEV1/FVC ratio due to a reduction in FEV1 relative to FVC; 
interestingly, ongoing postnatal growth restriction is not associated with airways obstruction.  The 
second “pathway to airway obstruction” is one where accelerated antenatal growth is maintained 
during infancy, and here the mechanism is due to a greater increase in FVC relative to FEV1.  
This paper (2) is the latest in many important papers from the Generation R cohort (9), and its main 
strength is the intense focus on growth between the second trimester and the first birthday.    A 
second strength is that the sample size of 5635 is large enough to place individuals into discrete 
growth categories whilst allowing for the inevitable missingness of data.  No study is perfect, and the 
Generation R cohort did not measure infant lung function so we are blind to any possible change in 
neonatal lung function trajectory associated with change in weight.  A second relative limitation is 
that the clinical relevance of early growth patterns is not clear in this cohort since the groups with 
reduced FEV1/FVC were not at increased risk for asthma; restricted postnatal weight gain was 
associated with a borderline increased risk for asthma. A further limitation is that post 
bronchodilator lung function was not determined so we do not know whether the reduced FEV1/FVC 
ratio is fixed or reversible. 
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The work from the Generation R cohort and others continues to give insight into the early origins of 
non-communicable diseases (NCD) in adulthood, including COPD, ischaemic heart disease and type II 
diabetes mellitus. The 1995 “fetal origins” hypothesis (10) considered the relationship between fetal 
exposures and risk for NCDs, whilst the 2004 concept of “developmental plasticity” (11) considered 
how the antenatal and postnatal environment both contribute to phenotype.  The observations 
described in the present study (2) are consistent with the model of developmental plasticity since 
both antenatal and postnatal growth had implications for obstructive lung function.  The results 
presented here (2) are also possibly the first to demonstrate that the same phenotype can be 
reached via different pathways.   
So where do we go from here? The importance of maternal health and wellbeing during pregnancy 
and early feeding practice to NCD risk in offspring has long been recognised (12). These findings add 
to the mountain of evidence that there is a window of opportunity to intervene and prevent 
obstructive airway disease, and this window is relatively wide open during the thousand days 
between conception and the second birthday.  The burden of COPD is rising and in the FEV1/FVC 
ratio we have an outcome which can be measured many years before COPD symptoms emerge, 
interventions which involve optimising nutrition and air quality are now required to reduce COPD 
prevalence in 2100. 
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Figure legend. Schematic diagram illustrating a number of pathways to “normal” and “abnormal” 
lung function.  The two solid lines indicate fixed trajectories throughout the lifecourse from 
conception to 25 year of age.  The dashed line corresponds to those individuals whose lung function 
changes from “reduced” to “normal”.  The dotted line tracks those whose lung function is initially 
“normal” but becomes “abnormal”. 
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Figure legend. Schematic diagram illustrating a number of pathways to “normal” and “abnormal” lung 
function.  The two solid lines indicate fixed trajectories throughout the lifecourse from conception to 25 year 
of age.  The dashed line corresponds to those individuals whose lung function changes from “reduced” to 
“normal”.  The dotted line tracks those whose lung function is initially “normal” but becomes “abnormal”.  
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